RESEARCH-USE BIOSIMILAR ANTIBODY
Enokizumab
Monoclonal antibody · IgG1
Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways.
TARGETIL9
YMonoclonal antibody
CATALOGSC-BS-574
CATALOG NUMBERSC-BS-574
MOLECULAR WEIGHTApprox. 145.5 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways.
Enokizumab is a recombinant research-use antibody directed against IL9.